Quantitation of pyridyloxobutyl DNA adducts in nasal and oral mucosa of rats treated chronically with enantiomers of N'-nitrosonornicotine.

N'-Nitrosonornicotine (NNN) is one of the most important strong carcinogens in tobacco products and is believed to play a significant role in the induction of esophageal cancer in smokers and oral cavity cancer in snuff dippers. NNN is metabolically activated through cytochrome P450-catalyzed alpha-hydroxylation. 2'-Hydroxylation produces a reactive intermediate 4-(3-pyridyl)-4-oxobutanediazohydroxide (7), which alkylates DNA to form pyridyloxobutyl (POB)-DNA adducts. DNA pyridyloxobutylation from NNN treatment, as measured by released 4-hydroxy-1-(3-pyridyl)-1-butanone (HPB, 8), has been observed in vitro and in vivo. In the present study, we have used liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS) to analyze specific POB-DNA adducts in the nasal olfactory, nasal respiratory, and oral mucosa of F344 rats treated chronically with (R)-NNN or (S)-NNN in the drinking water (10 ppm, 1-20 weeks). Adduct levels in the nasal respiratory mucosa exceeded those in the nasal olfactory and oral mucosa. (R)-NNN treatment generated 2-4 times more adducts in the nasal olfactory and respiratory mucosa than did (S)-NNN at most time points. O(2)-[4-(3-Pyridyl)-4-oxobut-1-yl]thymidine (O(2)-POB-dThd, 11) predominated in the nasal olfactory and respiratory mucosa, followed by 7-[4-(3-pyridyl)-4-oxobut-1-yl]guanine (7-POB-Gua, 14). Levels of O(2)-[4-(3-pyridyl)-4-oxobut-1-yl]cytosine (O(2)-POB-Cyt, 13) and O(6)-[4-(3-pyridyl)-4-oxobut-1-yl]-2'-deoxyguanosine (O(6)-POB-dGuo, 12) were significantly lower. In the oral mucosa, the opposite stereoselectivity was observed, with (S)-NNN treatment producing 3-5 times more POB-DNA adducts than did (R)-NNN. O(2)-POB-dThd and 7-POB-dGuo were the two major adducts, and their levels were similar. Overall, POB-DNA adduct formation in the nasal olfactory and nasal respiratory mucosa was similar to that previously observed in the lung, whereas in the oral mucosa, the trend resembled that in the esophagus. These results indicate that different mechanisms are involved in NNN metabolism and tumorigenesis in rat nasal and oral tissues. NNN enters the nasal mucosa through the circulation, and tissue-specific metabolism is important, while in the oral mucosa, direct exposure and local activation both play significant roles. Our results also support the potential importance of NNN as an oral carcinogen in people who use smokeless tobacco products.

[1]  S. Hecht,et al.  Identification of adducts formed in the reactions of 5'-acetoxy-N'-nitrosonornicotine with deoxyadenosine, thymidine, and DNA. , 2008, Chemical research in toxicology.

[2]  S. Hecht,et al.  Analysis of pyridyloxobutyl DNA adducts in F344 rats chronically treated with (R)- and (S)-N'-nitrosonornicotine. , 2007, Chemical research in toxicology.

[3]  Iarc Monographs,et al.  Smokeless tobacco and some tobacco-specific N-nitrosamines. , 2007, IARC monographs on the evaluation of carcinogenic risks to humans.

[4]  S. Hecht,et al.  Quantitation of pyridyloxobutyl DNA adducts of tobacco-specific nitrosamines in rat tissue DNA by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry. , 2006, Chemical research in toxicology.

[5]  Stephen S Hecht,et al.  Tobacco-specific nitrosamines in new tobacco products. , 2006, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[6]  S. Hecht,et al.  Identification of adducts formed in the reaction of 5'-acetoxy-N'-nitrosonornicotine with deoxyguanosine and DNA. , 2006, Chemical research in toxicology.

[7]  S. Hecht,et al.  Identification of an acetaldehyde adduct in human liver DNA and quantitation as N2-ethyldeoxyguanosine. , 2006, Chemical research in toxicology.

[8]  S. Hecht,et al.  Mass spectrometric analysis of relative levels of pyridyloxobutylation adducts formed in the reaction of DNA with a chemically activated form of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. , 2005, Chemical research in toxicology.

[9]  S. Hecht,et al.  Tobacco-Specific Nitrosamines and Their Pyridine-N-glucuronides in the Urine of Smokers and Smokeless Tobacco Users , 2005, Cancer Epidemiology Biomarkers & Prevention.

[10]  S. Hecht,et al.  Cytochrome P450 2A-catalyzed metabolic activation of structurally similar carcinogenic nitrosamines: N'-nitrosonornicotine enantiomers, N-nitrosopiperidine, and N-nitrosopyrrolidine. , 2005, Chemical research in toxicology.

[11]  S. Hecht,et al.  Identification of O2-substituted pyrimidine adducts formed in reactions of 4-(acetoxymethylnitrosamino)- 1-(3-pyridyl)-1-butanone and 4-(acetoxymethylnitros- amino)-1-(3-pyridyl)-1-butanol with DNA. , 2004, Chemical research in toxicology.

[12]  Shana J Sturla,et al.  Identification of adducts formed by pyridyloxobutylation of deoxyguanosine and DNA by 4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone, a chemically activated form of tobacco specific carcinogens. , 2003, Chemical research in toxicology.

[13]  S. Hecht,et al.  Enantiomeric composition of N'-nitrosonornicotine and N'-nitrosoanatabine in tobacco. , 2000, Carcinogenesis.

[14]  S. Hecht,et al.  Metabolism of N'-nitrosonornicotine enantiomers by cultured rat esophagus and in vivo in rats. , 2000, Chemical research in toxicology.

[15]  P. Wertz,et al.  Penetration of N-nitrosonornicotine (NNN) across oral mucosa in the presence of ethanol and nicotine. , 2000, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[16]  S. Murphy,et al.  Specificity of cytochrome P450 2A3-catalyzed alpha-hydroxylation of N'-nitrosonornicotine enantiomers. , 2000, Drug Metabolism And Disposition.

[17]  C. Weghorst,et al.  Expression of cytochrome P450 2A3 in rat esophagus: relevance to N-nitrosobenzylmethylamine. , 1999, Carcinogenesis.

[18]  S. Hecht,et al.  Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. , 1998, Chemical research in toxicology.

[19]  S. Hecht,et al.  Pyridyloxobutyl adduct O6-[4-oxo-4-(3-pyridyl)butyl]guanine is present in 4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone-treated DNA and is a substrate for O6-alkylguanine-DNA alkyltransferase. , 1997, Chemical research in toxicology.

[20]  T. Su,et al.  Expression of CYP2A genes in rodent and human nasal mucosa. , 1996, Drug metabolism and disposition: the biological fate of chemicals.

[21]  S. Murphy,et al.  Evidence for a high-affinity enzyme in rat esophageal microsomes which alpha-hydroxylates N'-nitrosonornicotine. , 1994, Carcinogenesis.

[22]  S. Hecht,et al.  Evidence supporting the role of DNA pyridyloxobutylation in rat nasal carcinogenesis by tobacco-specific nitrosamines. , 1994, Cancer research.

[23]  I. Gut,et al.  P450 in the rat and man: methods of investigation, substrate specificities and relevance to cancer. , 1994, Xenobiotica; the fate of foreign compounds in biological systems.

[24]  M. Djordjevic,et al.  Tobacco-specific N-nitrosamines and Areca-derived N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans. , 1994, Journal of toxicology and environmental health.

[25]  P. Souček,et al.  Cytochromes P-450 in rats: structures, functions, properties and relevant human forms. , 1992, Xenobiotica; the fate of foreign compounds in biological systems.

[26]  D. Hoffmann,et al.  A study of betel quid carcinogenesis. IX. Comparative carcinogenicity of 3-(methylnitrosamino)propionitrile and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone upon local application to mouse skin and rat oral mucosa. , 1991, Cancer letters.

[27]  S. Murphy,et al.  Comparative metabolism of N'-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by cultured F344 rat oral tissue and esophagus. , 1990, Cancer research.

[28]  S. Hecht,et al.  Evidence for 4-(3-pyridyl)-4-oxobutylation of DNA in F344 rats treated with the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N'-nitrosonornicotine. , 1988, Carcinogenesis.

[29]  S. Hecht,et al.  Induction of oral cavity tumors in F344 rats by tobacco-specific nitrosamines and snuff. , 1986, Cancer research.

[30]  C. Squier,et al.  Enhanced penetration of nitrosonornicotine across oral mucosa in the presence of ethanol. , 1986, Journal of oral pathology.

[31]  R. Gupta,et al.  Enhanced sensitivity of 32P-postlabeling analysis of aromatic carcinogen:DNA adducts. , 1985, Cancer research.

[32]  S. Hecht,et al.  Effects of chronic ethanol consumption on the metabolism and carcinogenicity of N'-nitrosonornicotine in F344 rats. , 1984, Cancer research.

[33]  S. Hecht,et al.  Metabolism of tobacco-specific nitrosamines by cultured rat nasal mucosa. , 1983, Cancer research.

[34]  G. Williams,et al.  Metabolism of N'-nitrosonornicotine by cultured rat esophagus. , 1982, Carcinogenesis.

[35]  E. Brittebo,et al.  Formation of tissue-bound N'-nitrosonornicotine metabolites by the target tissues of Sprague-Dawley and Fisher rats. , 1981, Carcinogenesis.

[36]  S. Hecht,et al.  Comparative carcinogenicity in F344 rats of the tobacco-specific nitrosamines, N'-nitrosonornicotine and 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone. , 1980, Cancer research.